4. The Silent Rounds

The fishing boat slipped through the predawn darkness like a ghost on the water.

Priya sat huddled in the bow, Meera's laptop wrapped in oilcloth and pressed against her chest. The old fisherman—his name was Gangadhar, he had told her, and he had been plying these waters since before she was born—had not asked questions after she offered him triple his usual fare. He simply untied his boat, cranked the wheezing outboard motor, and pointed the bow north toward Tejaswini Nagar.

Behind them, the glow of the fire had faded into the mist, but Priya could still see it when she closed her eyes: the column of smoke rising from the mangroves, the dark SUV, the men's voices sharp and businesslike. She did not know if Meera was alive. She did not know if the men had taken her, or hurt her, or simply destroyed the evidence and left her stranded in the swamp. And she could not afford to find out. She had the laptop. She had the data. She had the knowledge that twenty-three people—at least twenty-three—had died because a pharmaceutical company had decided their lives were an acceptable trade-off for efficacy metrics.

It took four hours to reach Tejaswini Nagar. Gangadhar dropped her at a fishing jetty on the southern edge of the city, where the morning catch was already being unloaded in baskets of silver and red. Priya paid him with all the cash in her wallet and pressed another five hundred rupees into his calloused hand.

"For your silence," she said.

The old man looked at the money, then at her face. "I have seen many things on the water, daughter," he said quietly. "I have learned when to speak and when to be silent. Go with God."

She went.

Her rented room felt smaller than it had two days ago, as if the walls had contracted in her absence. Priya locked the door, drew the curtains, and opened Meera's laptop on the rickety desk. The battery was at thirty-one percent. She plugged it into the wall socket and began to read.

The laptop was a trove of horrors, meticulously organized. Meera had been keeping records for two years, ever since her dismissal from PharmaGenexia. There were internal emails, laboratory reports, patient monitoring data, financial records, and a series of increasingly desperate letters addressed to regulatory agencies that had either ignored her or responded with form-letter reassurances. But the most damning file was the one labeled Serenity Protocol.

Priya opened it with trembling fingers.

The Serenity Protocol was a document dated three weeks earlier, authored by Dr. Arvind Kapadia and addressed to the PharmaGenexia executive board. It outlined a plan for a "large-scale efficacy demonstration" to be conducted at The Gilded Oaks Sanctuary during the upcoming monsoon health camp. The protocol called for the simultaneous administration of the GerontoVive viral vector to all forty-seven residents of the east wing, at dosages ranging from 5 milliliters to 15 milliliters. The residents would be monitored in real time through wearable biosensors, and the data would be streamed to a private server accessible to PharmaGenexia's investors.

The objective, according to the protocol, was to "demonstrate the scalability and consistency of GerontoVive's therapeutic effects across a diverse geriatric population." The document included detailed statistical projections of expected outcomes. The projections for efficacy were optimistic. The projections for adverse events were buried in a footnote on page thirty-four: "Anticipated cardiac event rate: 8-12% of subjects. Acceptable within the demographic risk profile."

Eight to twelve percent. Out of forty-seven residents, that meant four to six deaths. Four to six human beings whose hearts would stop because Dr. Kapadia had decided their sacrifice was acceptable.

Priya pushed back from the desk and walked to the window. The monsoon rain had stopped, leaving the streets slick and gleaming. In the distance, she could see the lights of the capital district, where politicians and regulators and PharmaGenexia executives were sleeping in comfortable beds, unaware that their complicity was about to be exposed. Or perhaps not unaware. Perhaps fully aware, and simply indifferent.

She needed to stop the health camp. But Meera had been right: going to the authorities was futile. The police were compromised. The regulators were captured. The politicians were bought. The only way to stop the Serenity Protocol was to make it impossible for PharmaGenexia to proceed in secret. To shine a light so bright that no amount of money or influence could hide what was happening.

She needed to intercept the investors' broadcast.

But the broadcast was encrypted, accessible only through a secure server that required authentication credentials. She did not have those credentials. She did not know anyone who did. And the health camp was six days away.

Priya sat down at the desk again and began to work through the problem with the methodical focus she had learned during her years as an investigative journalist. Every system had a weakness. Every secure network had an access point. Every organization had someone who could be persuaded, compromised, or turned.

She spent the next two days mapping PharmaGenexia's corporate structure from the information on Meera's laptop. The company was a hydra-headed beast, with subsidiaries and shell companies and research partnerships spread across three continents. But the Serenity Protocol was being run through a specific division—the Emerging Markets Gerontology Unit—and the broadcast was being managed by a small IT team based in the capital.

On the third day, she found her access point.

His name was Ravi Shetty, and he was a junior network administrator in PharmaGenexia's IT department. He was twenty-six years old, had graduated from a second-tier technical college, and had been working at PharmaGenexia for eighteen months. His social media profiles revealed a young man with expensive tastes and modest means—photos of designer watches he could not afford, posts complaining about his salary, comments on luxury car forums expressing frustration that his "talents were being wasted" in a support role.

Priya created a fake profile on the professional networking platform that Ravi frequented. She posed as a talent recruiter for a competing pharmaceutical company, a woman named Leela Rao who specialized in poaching disaffected junior employees with offers of better pay and more responsibility. She sent Ravi a connection request with a carefully worded message about "exciting opportunities" in the industry.

He accepted within two hours.

The conversation that followed was delicate, a dance of hints and insinuations. Priya-Leela praised Ravi's technical skills. She expressed sympathy for the frustrations of working in a large corporation. She dangled the possibility of a senior network architect position with a forty percent salary increase, contingent on "a demonstration of access and capability."

"What kind of demonstration?" Ravi typed.

"I understand your current employer is running a private broadcast next week," Priya-Leela replied. "A demonstration for investors. If I could see proof of access to that stream—credentials, encryption keys, the server address—it would tell me everything I need to know about your level of clearance and technical competence."

There was a long pause. Then: "That's proprietary information. I could get fired."

"You could also get hired. At a forty percent increase. With a signing bonus."

Another pause, longer this time. Priya watched the cursor blink on her screen, her heart pounding.

"I'll see what I can do," Ravi typed finally.

The next twenty-four hours were agony. Priya barely slept, barely ate, surviving on chai and the adrenaline that coursed through her system like an electric current. She checked her messages obsessively, waiting for Ravi's response. She reviewed Meera's files again and again, memorizing the details of the Serenity Protocol, the names of the victims, the clinical data that proved the viral vector was killing people.

On the evening of the fourth day, Ravi sent her a link. It was a temporary access token to a test server, he explained—a staging environment where the broadcast team was running dry runs of the investors' stream. The token would expire in twelve hours, but if she logged in at the right time, she would be able to watch the rehearsal.

Priya clicked the link.

The screen filled with a multi-panel view of The Gilded Oaks Sanctuary's east wing. Cameras had been installed in the corridors, the nursing station, and what appeared to be individual patient rooms. The resolution was high, the angles carefully chosen. This was not a medical monitoring system. This was a television production.

In the test stream, actors or staff members were walking through the corridors, simulating the flow of the actual event. A voiceover track played in the background: "Welcome, honored investors, to the Serenity Protocol Demonstration. Today, you will witness the future of geriatric medicine..."

Priya recorded everything. The stream, the voiceover, the camera angles, the timing. She captured screenshots of the interface, the server addresses, the authentication protocols. And as she watched, she began to understand the full scope of what PharmaGenexia was planning.

The health camp was not just a demonstration. It was a spectacle. The investors would be watching from luxury hotels and private offices around the world, connected through encrypted channels. They would see the residents lined up for their injections, smiling and trusting, unaware that they were being used as props in a presentation designed to sell a product that was killing them. And when the cardiac events began—when the four to six "acceptable" deaths occurred—the investors would be reassured that the risk was manageable, that the product was ready for market, that the deaths of a few old people were a small price to pay for the promise of extended life for the wealthy.

Priya closed the laptop and sat in the darkness of her room, her hands shaking with rage and horror. She had the evidence now. She had the means to intercept the broadcast. But she needed more than evidence. She needed a plan.

The health camp was three days away.

On the morning of the fifth day, she called Ramesh Nair at the Sundara Chronicle.

"Ramesh, I need your help."

"I was afraid you'd say that." His voice was heavy with resignation. "The temporary credential I gave you—someone from PharmaGenexia's legal department called the editor yesterday, asking about a woman claiming to be a Chronicle journalist who had been asking questions at a nursing home. I covered for you, but Priya, whatever you're doing, you need to be careful."

"I'm way past careful." Priya told him everything. The list, the bodies, the viral vector, the Serenity Protocol, the investors' broadcast. She spoke for nearly an hour, the words pouring out in a torrent, and when she was finished, Ramesh was silent for a long time.

"Twenty-three deaths," he said finally. "You're certain?"

"At least twenty-three that Meera could confirm. Probably more. And the health camp will add to the count unless we stop it."

"And your plan is to intercept a private corporate broadcast and expose it to the public? Do you have any idea how many laws that violates?"

"Less than the number of people who will die if I don't."

Another silence. Priya could hear Ramesh breathing on the other end of the line, the slow rhythm of a man wrestling with his conscience.

"If I help you," he said, "I could lose my job. I could go to prison. The Chronicle could be sued into bankruptcy."

"I know."

"But if I don't help you, those people will die, and I'll have to live with that for the rest of my life."

"That's the choice."

Ramesh sighed, a sound that seemed to come from somewhere deep in his bones. "I know a broadcast engineer who used to work for the state television network. She was fired for refusing to censor a documentary about the fishing industry. She might be willing to help. And I have access to the Chronicle's satellite uplink—the one we use for live election coverage. If you can get the stream to me, I can push it out to every news affiliate in Sundara Pradesh."

"Thank you, Ramesh."

"Don't thank me yet. Thank me if we're both still out of prison next week."

The next two days were a blur of preparation. The broadcast engineer—her name was Kamala, a fierce woman in her fifties with silver-streaked hair and the technical skills of a wizard—set up a relay system in Priya's rented room. She configured the satellite uplink, tested the signal strength, and walked Priya through the process of intercepting and rebroadcasting the encrypted stream.

"The hardest part is getting the initial access," Kamala explained. "Once you're in, the encryption is manageable. But the moment you start broadcasting, PharmaGenexia's security team will know something is wrong. They'll try to shut you down. You might have five minutes before they lock you out, maybe less. Make those minutes count."

On the morning of the monsoon health camp, Priya woke before dawn. She dressed in a simple salwar kameez, the kind of clothing that would not attract attention. She packed her laptop, a portable charger, and a small camera into an unremarkable canvas bag. She checked her press credential, still valid for two more days. And then she drove to The Gilded Oaks Sanctuary.

The parking lot was already filling with cars when she arrived—families dropping off elderly relatives for what they believed was a routine health screening, nurses in pale blue uniforms directing the flow of foot traffic, security guards posted at every entrance. Priya spotted Inspector D'Souza near the main gate, his barrel chest swelling with self-importance as he supervised the operation. She avoided him and entered through the service entrance, using the same white coat and clipboard trick that had worked before.

Inside, the east wing had been transformed. The corridors were lined with wheelchairs and gurneys, each occupied by an elderly resident wearing a paper gown and a plastic identification bracelet. Nurses moved among them with clipboards and syringes, checking dosages, recording vital signs. In the corner of the common room, a large screen displayed a live feed of the investors' interface, currently showing a PharmaGenexia logo and the words "Serenity Protocol—Investor Demonstration—Confidential".

The injections were scheduled to begin at ten o'clock.

At nine-thirty, Priya slipped into an empty storage closet near the nursing station. She opened her laptop, connected to the sanctuary's Wi-Fi network using the credentials Kamala had extracted from the test server, and navigated to the broadcast interface. The stream was already live, though the cameras were still showing empty rooms and corridors.

At nine-forty-five, the investors began to log in. Priya watched the participant counter tick upward—ten, twenty, fifty, a hundred. Each one represented a person with money and influence, a person who had been told they were about to witness a breakthrough in medical science.

At nine-fifty-five, Dr. Arvind Kapadia walked into the frame. He was dressed in a spotless white coat, his silver hair perfectly combed, his smile warm and avuncular. He stood before the main camera and began to speak.

"Good morning, honored guests. Welcome to The Gilded Oaks Sanctuary and the Serenity Protocol Demonstration. Today, you will witness the culmination of five years of research into one of humanity's oldest dreams: the extension of healthy life..."

Priya's fingers flew over her keyboard. She had configured the relay program to duplicate the stream and send it to Ramesh's satellite uplink. But she needed a window of opportunity—a moment when the security team was distracted, when the encryption was vulnerable, when she could seize control of the broadcast.

That moment came at ten-oh-two.

One of the nurses in the east wing called out that a resident had fainted. The cameras swiveled toward the commotion, and for a brief moment, the security team's attention was divided. Priya struck, executing the code that Kamala had written, and watched as the stream's encryption cracked open like an egg.

The feed went live.

Not just to the investors, but to the Sundara Chronicle's satellite uplink, which Ramesh had patched into every news affiliate that would accept the signal. Priya could not see who was watching—could not know if anyone was watching—but she had done her part. The broadcast was out.

She turned her attention back to the screen. Dr. Kapadia was still speaking, unaware that his audience had just expanded by several orders of magnitude.

"...and so, with great pride, I invite you to observe the administration of GerontoVive to the residents of the east wing. Each resident has been carefully assessed and dosed according to our optimized protocol. The wearable biosensors you see on their wrists will provide real-time data on their physiological responses..."

The injections began. Priya watched in horror as the nurses, smiling and professional, inserted IV lines into the arms of elderly residents who had no idea they were being used as experimental subjects. The residents smiled back. They trusted these people. They believed they were receiving vitamins, or supplements, or something that would help them live longer and feel better.

She switched to the relay stream and began to narrate over the footage, her voice steady despite the trembling in her hands.

"What you are watching is not a medical procedure. It is a criminal experiment. The substance being injected into these residents is an unapproved gene therapy vector that has been linked to at least twenty-three deaths in the past six months. The company behind this demonstration, PharmaGenexia, has been warned repeatedly about the risks, and has chosen to proceed in secret. The man speaking is Dr. Arvind Kapadia, who has falsified safety data and concealed adverse events. These residents did not consent to this. Their families did not consent. They are being sacrificed for profit."

She paused, her throat dry, and continued.

"My name is Priya Kapoor. I am a journalist. My uncle was one of the victims. I am broadcasting this from inside The Gilded Oaks Sanctuary, and I am asking anyone who is watching—anyone with the power to intervene—to stop this before more people die."

The response was immediate and violent.

The investors' stream went dark, replaced by a PharmaGenexia logo and the words "Technical Difficulties—Please Stand By." In the corridors of the east wing, alarms began to sound. Nurses stopped mid-injection, looking around in confusion. Dr. Kapadia's voice, amplified over the intercom, cut through the noise: "Security, locate the intruder. Seal the exits. No one leaves."

Priya grabbed her laptop and slipped out of the storage closet. The corridor was chaos—nurses running, residents crying out in fear, security guards shouting into their radios. She moved through the confusion like a shadow, heading for the service exit.

But when she reached the door, Inspector D'Souza was waiting for her.

"Miss Kapoor." His smile was gone. In its place was something cold and hard. "I told you to let this go. I gave you every opportunity to walk away. And now look at what you've done."

"Get out of my way, Inspector."

"I'm afraid I can't do that." He stepped forward, his hand resting on the baton at his belt. "You're trespassing on private property. You've hacked into a secure corporate network. You've disrupted a licensed medical procedure. And I have orders to detain you pending an investigation into your activities."

"Orders from whom?"

D'Souza's smile returned, thin and humorless. "From people you shouldn't have made enemies of."

Behind him, two security guards moved into position, blocking the exit. Priya's mind raced, calculating escape routes, weighing options. She had done what she came to do. The broadcast was out. The world had seen. But if she was arrested now, if she disappeared into the system that PharmaGenexia had so thoroughly corrupted, the story might die with her.

She took a step back, clutching the laptop to her chest.

And then the lights went out.

The entire east wing plunged into darkness, the alarms cutting off mid-wail. Someone screamed. Someone else shouted an order. In the confusion, a hand grabbed Priya's arm and pulled her sideways, through a door she hadn't seen, into a narrow service corridor.

"Don't speak," a voice whispered. "Just follow me."

It was Anjali.

The young nurse led her through a maze of maintenance passages, their feet echoing on concrete floors, their breath loud in the darkness. Emergency lights flickered on, casting the corridor in a pale orange glow. Anjali moved with the confidence of someone who had walked these passages many times before, and within minutes they had emerged through a laundry chute into the loading dock, then through the service gate, then into the street.

"My car is parked two blocks away," Anjali said, her voice shaking. "I'll take you somewhere safe. But we have to go now."

Priya looked back at The Gilded Oaks Sanctuary. The lights were coming back on, the alarms resuming their electronic wail. In the distance, she could hear sirens—police, or ambulances, or both. She did not know if the injections had been stopped. She did not know if anyone had listened to her broadcast. She did not know if the residents of the east wing were alive or dead.

She only knew that she had thrown a stone into still water, and the ripples were spreading in every direction.

"Go," she said to Anjali. "Take me wherever you can."

The car pulled away from the curb, and The Gilded Oaks Sanctuary receded behind them into the grey monsoon morning, its white walls looking less like a sanctuary and more like a fortress under siege.